Skip to NavigationSkip to content

News

The approval relates to patients for whom conventional therapies for the prevention of structural joint damage have not been effective.
Under the terms of the agreement, the EU will also have the option to provide a proportion of the reserved doses to low and middle-income nations.
President Trump has outlined his “America First Health Plan” on Thursday, which will allow the easy importation of prescription drugs from Canada.
British consumers have increasingly turned to community pharmacies during the coronavirus pandemic, according to a new study.
The top 10 news stories this week focus on coronavirus vaccine trials, as around one in seven patients who have received Russia’s vaccine against...
The FDA has requested an additional study in older children being treated with Novartis’ Zolgensma in the review process for its spinal muscular...
The UK Government’s track and trace app for COVID-19 has finally launched in England and Wales, after months of delays and controversy over the...
The FDA has issued an Emergency Use Authorization (EUA) for the first antibody (serology) point-of-care test for coronavirus.
Some supplements billed as ‘smart drugs’ may contain unapproved drugs in potentially dangerous combinations and doses, according to a new study.
Gilead has agreed to pay $97 million to resolve claims from the US Government that it used an independent charity to pay illegal kickbacks to cover...
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches